[1]Li J J, Zhao S P, Zhao D, et al. 2023 China guidelines for lipid management[J]. J Geriatr Cardiol, 2023, 20(9): 621-663.
[2]Mach F, Baigent C, Catapano A L et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)[J]. Eur Heart J, 2020, 41(1): 111-188.
[3]Grundy S M, Stone N J, Bailey A L, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines[J]. J Am Coll Cardiol, 2019, 73(24): 3168-3209.
[4]Byrne R A, Rossello X, Coughlan J J, et al. 2023 ESC guidelines for the management of acute coronary syndromes[J]. Eur Heart J, 2023, 44(38): 3720-3826.
[5]中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 中国慢性冠脉综合征患者诊断及管理指南[J]. 中华心血管病杂志, 2024, 52(6): 589-614.
[6]Scanlon P J, Faxon D P, Audet A M, et al. ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American college of cardiology/American heart association task force on practice guidelines (committee on coronary angiography) developed in collaboration with the society for cardiac angiography and interventions[J]. Circulation, 1999, 99(17): 2345-2357.
[7]Arnett D K, Blumenthal R S, Albert M A, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines[J]. Circulation, 2019, 140(11): e596-e646.
[8]Standring S. Gray's anatomy: the anatomical basis of clinical practice[M]. Amsterdam: Elsevier, 2016.
[9]Tombolini B, Borrelli E, Sacconi R, et al. Diabetic macular ischemia[J]. Acta Diabetol, 2022, 59(6): 751-759.
[10]Sun C, Ladores C, Hong J, et al. Systemic hypertension associated retinal microvascular changes can be detected with optical coherence tomography angiography[J]. Sci Rep, 2020, 10(1): 9580.
[11]Donati S, Maresca A M, Cattaneo J, et al. Optical coherence tomography angiography and arterial hypertension: a role in identifying subclinical microvascular damage?[J]. Eur J Ophthalmol, 2021, 31(1): 158-165.
[12]Samara W A, Shahlaee A, Adam M K, et al. Quantification of diabetic macular ischemia using optical coherence tomography angiography and its relationship with visual acuity[J]. Ophthalmology, 2017, 124(2): 235-244.
[13]He Y, Qin M Z, Cao K, et al. Assessment of the impact of low-density lipoprotein cholesterol on retinal vessels using optical coherence tomography angiography[J]. Lipids Health Dis, 2024, 23(1): 301.
[14]魏文斌. OCT血流成像图谱[M]. 北京: 人民卫生出版社, 2016.
[15]Ge X, Liu X L, Sun T N, et al. Correlation between the severity of coronary artery disease and retinal artery disease and the therapeutic effect of captopril[J]. Altern Ther Health Med, 2025, 31(1): 361-365.
[16]Kalra G, Zarranz-Ventura J, Chahal R, et al. Optical coherence tomography (OCT) angiolytics: a review of OCT angiography quantitative biomarkers[J]. Surv Ophthalmol, 2022, 67(4): 1118-1134.
[17]Inker L A, Eneanya N D, Coresh J, et al. New creatinine-and cystatin C-based equations to estimate GFR without race[J]. N Engl J Med, 2021, 385(19): 1737-1749.
[18]Al-Sheikh M, Tepelus T C, Nazikyan T, et al. Repeatability of automated vessel density measurements using optical coherence tomography angiography[J]. Br J Ophthalmol, 2017, 101(4): 449-452.
[19]Takayama K, Kaneko H, Ito Y, et al. Novel classification of early-stage systemic hypertensive changes in human retina based on OCTA measurement of choriocapillaris[J]. Sci Rep, 2018, 8(1): 15163.
[20]Sun Z H, Yang D W, Tang Z Q, et al. Optical coherence tomography angiography in diabetic retinopathy: an updated review[J]. Eye, 2021, 35(1): 149-161.
[21]Linde J J, Kelbæk H, Hansen T F, et al. Coronary CT angiography in patients with non-ST-segment elevation acute coronary syndrome[J]. J Am Coll Cardiol, 2020, 75(5): 453-463.
[22]Abbara S, Blanke P, Maroules C D, et al. SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: a report of the society of cardiovascular computed tomography guidelines committee: endorsed by the North American Society for Cardiovascular Imaging (NASCI)[J]. J Cardiovasc Comput Tomogr, 2016, 10(6): 435-449.
[23]Chua J, Chin C W L, Hong J, et al. Impact of hypertension on retinal capillary microvasculature using optical coherence tomographic angiography[J]. J Hypertens, 2019, 37(3): 572-580.
[24]Shin Y I, Nam K Y, Lee W H, et al. Peripapillary microvascular changes in patients with systemic hypertension: an optical coherence tomography angiography study[J]. Sci Rep, 2020, 10(1): 6541.
[25]Borrelli E, Battista M, Sacconi R, et al. Optical coherence tomography angiography in diabetes[J]. Asia Pac J Ophthalmol, 2021, 10(1): 20-25.
[26]Wang J, Jiang J, Zhang Y, et al. Retinal and choroidal vascular changes in coronary heart disease: an optical coherence tomography angiography study[J]. Biomed Opt Express, 2019, 10(4): 1532-1544.
[27]Zhong P T, Li Z X, Lin Y W, et al. Retinal microvasculature impairments in patients with coronary artery disease: an optical coherence tomography angiography study[J]. Acta Ophthalmol, 2022, 100(2): 225-233.
[28]Zhong P T, Hu Y J, Jiang L, et al. Retinal microvasculature changes in patients with coronary total occlusion on optical coherence tomography angiography[J]. Front Med, 2021, 8: 708491.
|